Related Experiment Video
Updated: Jul 17, 2026

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
Published on: June 22, 2015
Onyx: a unique neuroembolic agent
Michael Ayad1, Eric Eskioglu, Robert A Mericle
1Vanderbilt University, Department of Neurological Surgery, Vanderbilt University Medical Center, MCN T-4224, Nashville, TN 37212, USA. michael.ayad@vanderbilt.edu
Abstract:
Rupture of a cerebral arteriovenous malformation can result in devastating hemorrhage with a possibility of serious neurological injury or death. Endovascular embolization is an important adjunct in the treatment of cerebral arteriovenous malformations, and in a small number of cases may provide definitive treatment. Currently available embolic agents have several shortcomings, including the possibility of recanalization, adhesiveness to the endovascular microcatheter and suboptimal handling at the time of surgical resection. Onyx is an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide that was approved by the US FDA in July 2005 as an embolic agent for brain arteriovenous malformations. Although long-term follow-up is limited, this agent appears to offer several advantages over the other available embolic agents for the endovascular management of arteriovenous malformations and other vascular lesions.
More Related Videos
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Neurotransmitters
Neurotransmitters
Synesthesia
Neurons: The Axon
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
Neuronal Communication

